Nichol also serves as VP, controller and principal accounting officer. She joined Zimmer Biomet in September 2019 from pharma giant Endo International, where she was SVP, controller and chief accounting officer.
“Nichol is pursuing another employment opportunity and her departure is not the result of any disagreement regarding the company’s financial reporting or accounting policies, procedures, estimates or judgments,” Zimmer Biomet said in a filing with the U.S. Securities and Exchange Commission.
Derek Davis will serve as principal accounting officer and interim controller and chief accounting officer while the company searches for Nichol’s replacement. Davis previously served as chief accounting officer and principal accounting officer from May 2007 to June 2015, when he became VP of Global Integration. He has been VP of Finance Integration since August 2020.
Zimmer Biomet’s filing did not name Nichol’s next employer or say whether she’ll stay in the medtech industry. She signed a noncompete agreement when she joined Zimmer Biomet in 2019, restricting her from joining competitors within 18 months of her departure.